Drug Information

Drug General Information
Drug ID
D0O2RN
Former ID
DNC004507
Drug Name
N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526204]
Formula
C17H19N3O
Canonical SMILES
CC1=CC=C(C=C1)C(=O)NC(=NCCC2=CC=CC=C2)N
InChI
1S/C17H19N3O/c1-13-7-9-15(10-8-13)16(21)20-17(18)19-12-11-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H3,18,19,20,21)
InChIKey
ZVURELUSYUBEQF-UHFFFAOYSA-N
PubChem Compound ID
22149251
Target and Pathway
Target(s) Sodium channel protein type 5 subunit alpha Target Info Inhibitor [526204]
KEGG Pathway Adrenergic signaling in cardiomyocytes
PathWhiz Pathway Muscle/Heart Contraction
Reactome Interaction between L1 and Ankyrins
WikiPathways SIDS Susceptibility Pathways
Cardiac Progenitor Differentiation
References
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.